Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (281-290 of 352) with videos related to

Pageof 36
Sort By:
The Journal of Clinical Investigation|April 25, 2024
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancerXiaochao Tan, Shike Wang, Guan-Yu Xiao, et al.
Annals of Surgery|September 12, 2013
The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinomaAshleigh M Francis, Boris Sepesi, Arlene M Correa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2008
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancerRuth L Katz, Tanweer M Zaidi, Ricardo L Fernandez, et al.
Plos One|February 21, 2012
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parametersYong He, Zhen Zhou, Wayne L Hofstetter, et al.
Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.
Chest|November 20, 2020
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK MutationsAudra J Schwalk, David E Ost, Sahara N Saltijeral, et al.
The Annals of Thoracic Surgery|July 24, 2007
Proposed modification of nodal status in AJCC esophageal cancer staging systemWayne Hofstetter, Arlene M Correa, Neby Bekele, et al.
Innovations (Philadelphia, Pa.)|December 27, 2019
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary StandardizationKyle G Mitchell, David B Nelson, Erin M Corsini, et al.
Oncotarget|December 15, 2015
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cellsHongyu Li, Jing Hu, Shuhong Wu, et al.
The Annals of Thoracic Surgery|March 15, 2018
Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass ComponentsDavid B Nelson, Myrna C B Godoy, Marcelo F Benveniste, et al.
Pageof 36

Showing results (281-290 of 352) with videos related to

Sort By:
Pageof 36
The Journal of Clinical Investigation|April 25, 2024
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancerXiaochao Tan, Shike Wang, Guan-Yu Xiao, et al.
Annals of Surgery|September 12, 2013
The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinomaAshleigh M Francis, Boris Sepesi, Arlene M Correa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2008
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancerRuth L Katz, Tanweer M Zaidi, Ricardo L Fernandez, et al.
Plos One|February 21, 2012
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parametersYong He, Zhen Zhou, Wayne L Hofstetter, et al.
Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.
Chest|November 20, 2020
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK MutationsAudra J Schwalk, David E Ost, Sahara N Saltijeral, et al.
The Annals of Thoracic Surgery|July 24, 2007
Proposed modification of nodal status in AJCC esophageal cancer staging systemWayne Hofstetter, Arlene M Correa, Neby Bekele, et al.
Innovations (Philadelphia, Pa.)|December 27, 2019
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary StandardizationKyle G Mitchell, David B Nelson, Erin M Corsini, et al.
Oncotarget|December 15, 2015
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cellsHongyu Li, Jing Hu, Shuhong Wu, et al.
The Annals of Thoracic Surgery|March 15, 2018
Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass ComponentsDavid B Nelson, Myrna C B Godoy, Marcelo F Benveniste, et al.
Pageof 36